# Psychiatric safety of bimekizumab versus interleukin-23 inhibitors in psoriasis: A real-world TriNetX cohort study

**Authors:** Christina Tolete, Adam Friedman, Joaquin Calderon, Leonardo Tjahjono

PMC · DOI: 10.1016/j.jdin.2026.02.006 · 2026-02-23

## Full-text entities

- **Diseases:** psoriasis (MESH:D011565)
- **Chemicals:** interleukin-23 inhibitors (-), bimekizumab (MESH:C000625981)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13018952/full.md

---
Source: https://tomesphere.com/paper/PMC13018952